JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

Search

Integra LifeSciences Holdings Corp

Chiusa

SettoreSettore sanitario

10.82 -1.73

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

10.8

Massimo

11.11

Metriche Chiave

By Trading Economics

Entrata

479M

-5.4M

Vendite

-14M

402M

Margine di Profitto

-1.344

Dipendenti

4,396

EBITDA

526M

54M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+17.33% upside

Dividendi

By Dow Jones

Utili prossimi

24 feb 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-386M

869M

Apertura precedente

12.55

Chiusura precedente

10.82

Notizie sul Sentiment di mercato

By Acuity

78%

22%

324 / 352 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 feb 2026, 23:57 UTC

Utili

Naver Has Record Year Despite Weaker Final Quarter

5 feb 2026, 23:45 UTC

Azioni calde

Stocks to Watch: Amazon, Coty, Gen Digital, Roblox

5 feb 2026, 22:26 UTC

Utili

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9% -- Update

5 feb 2026, 22:00 UTC

Utili

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9%

5 feb 2026, 23:47 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

5 feb 2026, 23:47 UTC

Discorsi di Mercato

Nikkei May Fall After U.S. Tech Stock Drops -- Market Talk

5 feb 2026, 23:43 UTC

Discorsi di Mercato

Gold Falls on Spillover Impact From Cryptocurrencies' Selloff -- Market Talk

5 feb 2026, 23:37 UTC

Discorsi di Mercato

Glencore Shares Look Cheap After Failed Takeover Talks -- Market Talk

5 feb 2026, 23:20 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 5th Update

5 feb 2026, 23:11 UTC

Discorsi di Mercato

Amazon CEO Confident in Return on $200B Investment -- Market Talk

5 feb 2026, 23:09 UTC

Utili

Naver 2025 Net KRW1.820T Vs. Net KRW1.932T >035420.SE

5 feb 2026, 23:08 UTC

Utili

Naver 2025 Oper Pft KRW2.208T Vs. Pft KRW1.979T >035420.SE

5 feb 2026, 23:07 UTC

Utili

Naver 2025 Rev KRW12.035T Vs. KRW10.738T >035420.SE

5 feb 2026, 23:03 UTC

Discorsi di Mercato
Utili

REA's Update Looks Negative Despite A$200M Buyback -- Market Talk

5 feb 2026, 23:03 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Bitcoin Booster's $12 Billion Loss Headlines Crypto's Worst Day Since 2022 Crash -- WSJ

5 feb 2026, 23:00 UTC

Utili

Naver 4Q Net Profit Missed FactSet-Compiled Consensus

5 feb 2026, 23:00 UTC

Utili

Naver 4Q Net KRW164.60B Vs. Net KRW514.00B >035420.SE

5 feb 2026, 22:59 UTC

Utili

Naver 4Q Oper Pft KRW610.60B Vs. Pft KRW542.00B >035420.SE

5 feb 2026, 22:59 UTC

Utili

Naver 4Q Rev KRW3.195T Vs. KRW2.886T >035420.SE

5 feb 2026, 22:52 UTC

Utili

Alphabet Stock Is Taking a Hit After Strong Earnings. Don't Panic. -- Barrons.com

5 feb 2026, 22:45 UTC

Utili

Amazon Stock Falls Sharply on Earnings. Spending Continues to Soar. -- Barrons.com

5 feb 2026, 22:37 UTC

Discorsi di Mercato

Woolworths's Profit Margin Likely Faces 2Q Squeeze -- Market Talk

5 feb 2026, 22:11 UTC

Utili

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9% -- Update

5 feb 2026, 22:03 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 4th Update

5 feb 2026, 22:01 UTC

Utili

Reddit Stock Jumps on Earnings. CFO Cites Modest AI Spending. -- Barrons.com

5 feb 2026, 21:59 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

What's Next For Rio Tinto, Glencore After Deal Talks Fail? -- Market Talk

5 feb 2026, 21:51 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Saylor's Strategy Posts $12 Billion Quarterly Loss on Bitcoin Selloff -- WSJ

5 feb 2026, 21:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Basic Materials Roundup: Market Talk

5 feb 2026, 21:49 UTC

Utili

Why Google's Bad News Was Good News for Broadcom and Nvidia -- Barrons.com

5 feb 2026, 21:45 UTC

Utili

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9%

Confronto tra pari

Modifica del prezzo

Integra LifeSciences Holdings Corp Previsione

Obiettivo di Prezzo

By TipRanks

17.33% in crescita

Previsioni per 12 mesi

Media 13 USD  17.33%

Alto 13 USD

Basso 13 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Integra LifeSciences Holdings Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

3 ratings

0

Acquista

3

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

12.75 / 16.41Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Weak Bearish Evidence

Sentiment

By Acuity

324 / 352 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat